Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Comment by Hopefulhomerunon Dec 22, 2009 1:45pm
392 Views
Post# 16611255

RE: RE:...AZD103 Ongoing....Hopefulhomerun

RE: RE:...AZD103 Ongoing....HopefulhomerunThanks Denisack...  If I am hearing you correctly, a trial (including phase 2 trials) can be considered pivotal as long as they are designed to provide enough data to support marketing approval...... And by the way, where did you hear that their trial was designed to be a pivotal phase 2 trial? I could not find it documented anywhere, and I am trying to confirm if their intent/hope was to file for marketing appoval prior to completing a phase 3 trial. ( I am aware they received the fast-track designation for their drug)

GLTA 
Bullboard Posts